A new study shows that genetic testing could be used to determine which drugs will—and won't—work for patients with Candida auris (C. auris), a multidrug-resistant yeast that causes life-threatening ...

LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...

A project that implemented targeted screening for candida auris in ventilator-assisted healthcare facilities has found relatively high rates of colonization in nursing homes, and evidence that testing ...

Please provide your email address to receive an email when new articles are posted on . “However, we did not have much data about whether and how hospitals across the country were conducting C. auris ...

Candida auris, a drug-resistant fungus that spreads through healthcare facilities, is gaining ground across the United States ...

T2 Biosystems Inc. received a third FDA breakthrough device designation with its direct-from-blood molecular diagnostic test for Candida auris. The test joins its T2resistance panel and T2Lyme panel ...

“An inpatient has tested positive for C. auris, an emerging pathogen that is spreading in the U.S.,” a spokesperson for WVU Medicine said in a statement to local news outlets. “We are working with the ...

Please provide your email address to receive an email when new articles are posted on . In March, CDC researchers reported a 95% increase in cases of Candida auris in the U.S. from 2020 to 2021. Data ...

Findings published in the special Clinical Chemistry issue, "Genomics: Current & emerging trends in the clinical laboratory" Altogether, this means that healthcare professionals might waste precious ...

LEXINGTON, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that ...